Skip to Content
Merck
All Photos(1)

Documents

PP102

Sigma-Aldrich

IgG2a Antibody, Mouse

2.2 mg/mL, Chemicon®

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

mouse

Quality Level

antibody form

purified immunoglobulin

clone

monoclonal

manufacturer/tradename

Chemicon®

concentration

2.2 mg/mL

technique(s)

ELISA: suitable

shipped in

dry ice

target post-translational modification

unmodified

General description

Purity: 95% or greater

Application

Mouse IgG2a Monoclonal Antibody control validated for use in ELISA.
Research Category
Inflammation & Immunology
Research Sub Category
Immunoglobulins & Immunology

Physical form

Format: Purified
Purified immunoglobulin. Liquid containing no preservatives.

Storage and Stability

Maintain at -20°C in undiluted aliquots for up to 12 months. Do not thaw and refreeze.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.
R H Weisbart, D T Noritake, A L Wong, G Chan, A Kacena, K K Colburn, R H Weisbart et al.
Journal of immunology (Baltimore, Md. : 1950) (1950)
Martin Bentler et al.
Molecular therapy. Methods & clinical development, 30, 576-592 (2023-09-11)
De novo immune responses are considered major challenges in gene therapy. With the aim to lower innate immune responses directly in cells targeted by adeno-associated virus (AAV) vectors, we equipped the vector capsid with a peptide known to interfere with
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
Hahn, T; Bradley-Dunlop, DJ; Hurley, LH; Von-Hoff, D; Gately, S; Mary, DL; Lu et al.
BMC Cancer null
Aberrant activation of the interleukin-2 autocrine loop through the nuclear factor of activated T cells by nonleukemogenic human T-cell leukemia virus type 2 but not by leukemogenic type 1 virus.
Niinuma, A; Higuchi, M; Takahashi, M; Oie, M; Tanaka, Y; Gejyo, F; Tanaka, N; Sugamura et al.
Journal of virology null
Richard H Weisbart et al.
Molecular immunology, 39(13), 783-789 (2003-03-06)
Methods for cell type specific targeted intracellular delivery of proteins in vivo remain limited. A murine monoclonal anti-dsDNA antibody, mAb 3E10, was selectively transported into skeletal muscle cells in vivo. The antibody bound a 200 kDa protein only found in

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service